Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABVC, Altamira, Durect, Eisai, Evecxia, Horizon, Mabwell, Merck, Molecular Templates, Nuance, Nuvectis.

Biopharmas raising money in public or private financings, including: 180 Life Sciences, Annovis, Ctrl, Mosanna, Mydecine, Oncosec.

New hires and promotions in the biopharma industry, including: ACM Biolabs, Ascidian, Curevo, Hdax, Immutep, Jasper, Kyowa Kirin, Poseida, RS, Sana, Scholar Rock, Tune.

The top 10 med-tech stock gainers and losers for the week.

Med-tech firms raising money in public or private financings, including: Anpac Bio-Medical Science.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Genome Insight, Myomo, Omni Components, Ryzur, Ultima Genomics, Vander-Bend, Virgo Surgical Video.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Oncocyte.

New hires and promotions in the med-tech industry, including: Biostage, Ora.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Brim, CNS, Enanta, Everest, Merck.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aviceda, Evopoint, Evotec, Exevir Bio, JCR Pharmaceuticals, Merck, Nona Biosciences, Omeros, Sensorion, Sumitomo.